Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Low muscle mass, obesity, and cause-specific mortality in cancer patients: a nationwide cohort study.

Created on 06 Sep 2026

Authors

Dagyeong Lee, Bongseong Kim, Kyu-Won Jung, Ga Eun Nam, Sang Youl Rhee, Seonghye Kim, Sohyun Chun, In Young Cho, Kyungdo Han, Dong Wook Shin

Published in

Cancer causes & control : CCC. Volume 37. Issue 10. Sep 05, 2026. Epub Sep 05, 2026.

Abstract

Low muscle mass (LMM) is a risk factor for adverse health outcomes, but its prognostic relevance in cancer remains insufficiently studied. We investigated the independent and combined effects of LMM and obesity on mortality in cancer patients.
This cohort study included 635,867 cancer patients. LMM was defined as the lowest quartile on the appendicular skeletal muscle mass index (ASMI). Obesity was defined as body mass index ≥25 kg/m2 and abdominal obesity as waist circumference ≥90 cm (males) and ≥85 cm (females). Patients were classified into four groups based on muscle mass and obesity status. Cox proportional hazards models calculated adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) for mortality.
Compared with individuals in the highest ASMI quartile, LMM had significantly higher risks of all-cause (aHR 1.25, 95% CI 1.23-1.27), cancer-specific (aHR 1.21, 95% CI 1.19-1.23), cardiovascular (aHR 1.49, 95% CI 1.36-1.64), and respiratory mortality (aHR 2.26, 95% CI 1.99-2.56). While obesity was associated with lower mortality risks than non-obese status, the LMM with obesity group exhibited the highest risk for all-cause (aHR 1.22; 95% CI, 1.16-1.28) and cancer-specific mortality (aHR 1.22; 95% CI, 1.16-1.29).
LMM was independently associated with increased mortality in cancer patients, regardless of obesity status. The adverse effect was amplified in those with both LMM and obesity, but obesity alone showed a modest inverse association. These findings highlight the clinical relevance of evaluating muscle mass and body composition in cancer.

PMID:
42700202
Bibliographic data and abstract were imported from PubMed on 06 Sep 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 1
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement